aniject injection
chanelle animal health ltd. - ivermectin - solution for injection - 1 %w/v - bovine - endectoparasiticides
chaniject injection
chanelle animal health ltd. - ivermectin - solution for injection - 1 %v/w - bovine - endectoparasiticides
graniject 1 mg/ml ivi
sandoz sa (pty) ltd - granisetron hydrochloride - injection - each 1ml solution contains granisetron hydrochloride equiv. to granisetron 1,0 mg
graniject 3 mg/3ml ivi
sandoz sa (pty) ltd - granisetron hydrochloride - injection - each 3 ml solution contains granisetron hydrochloride equiv. to granisetron 3,0 mg
traniject 100 mg/ml (500 mg/5 ml) solution for intravenous injection
ambica international trading corporation; distributor: meedpharma medical supplies & equipment distributor - tranexamic acid - solution for intravenous injection - 100 mg/ml (500 mg/5 ml)
azilect rasagiline (as mesilate) 1 mg tablet blister pack
teva pharma australia pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: stearic acid; purified talc; mannitol; colloidal anhydrous silica; maize starch; pregelatinised maize starch - azilect is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
amiject 500 injection
beacon pharmaceuticals plc - amikacin - injection - 500 mg/2 ml
azilect
teva israel ltd - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
azilect
teva pharmaceutical industries ltd, israel - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
azilect
teva pharmaceutical industries ltd, israel - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.